Eisenstadt Richard I 4
4 · Altimmune, Inc. · Filed Aug 2, 2023
Insider Transaction Report
Form 4
Eisenstadt Richard I
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.0001
2023-07-31$2.81/sh+1,825$5,128→ 23,835 total
Footnotes (2)
- [F1]These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from February 1, 2023 through July 31, 2023.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 31, 2023.